@cpkotanidis.bsky.social
Editorial Fellow at New England Journal of Medicine | PostDoc at Harvard Med | DPhil University of Oxford | MD Aristoteleio
The win ratio method is gaining traction in #RCTs. Is it just a trend or a smarter way to look at composite hierarchical outcomes? We break it down in our latest Stats, STAT!๐ in NEJM Evidence. youtube.com/watch?v=jKtF... #stats @nejm.org @sarahgorey.bsky.social @chardin.bsky.social @ai.nejm.org
31.07.2025 11:41 โ ๐ 15 ๐ 4 ๐ฌ 4 ๐ 01/ ๐จ NEW #BeyondJournalClub w/ @nejm.org: REDUCE-AMI
What is the long term benefit of beta blockers in patients with preserved EF following an MI?
๐ฅ๏ธ: www.coreimpodcast.com/2025/06/25/b...
Early Invasive or Conservative Strategies for Older Patients With Acute Coronary Syndromes
In older patients with acute coronary syndrome, an early invasive strategy did not reduce all-cause mortality but decreased recurrent myocardial infarction and repeated revascularization. https://ja.ma/40hDK9G
24.06.2025 12:00 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0What is it like to be an NEJM editorial fellow for a year? This yearโs fellows discuss what they have learned, how their experience will help their career, and what surprised them. Apply for the 2026โ27 NEJM editorial fellowship by August 1. Learn more: nej.md/3cCQajB
#MedSky #MedEd
60-Second Journal Club: The SUMMIT trial examined cardiovascular outcomes of treatment with tirzepatide in patients with heart failure with preserved ejection fraction and obesity. Read the full trial results: nej.md/4hRGaTY
#MedSky #CardioSky @cpkotanidis.bsky.socialโฌ
Aspiration Thrombectomy for Coronary Stent Thrombosis Panel A: Coronary angiography revealing a large thrombus in the LAD artery stent. Panel B: The thrombus that was removed with the use of an aspiration catheter. Panel C: The stent that was dilated with a balloon at high pressure, which resulted in improved flow.
A 73-year-old woman presented with severe chest pain. She had undergone multivessel percutaneous coronary intervention 2.5 years earlier. Angiography revealed a large thrombus in an LAD artery stent (shown in videos). Read the full case details: nej.md/4jC2aSa
#MedSky #CardioSky
Really enjoying @cpkotanidis.bsky.socialโs fascinating presentation on his interesting work at @brighamandwomens.bsky.social on identifying risk markers of CVD in patients with IMIDs ๐คฉ๐๐๐
06.05.2025 20:30 โ ๐ 2 ๐ 1 ๐ฌ 1 ๐ 0New research alert: Our latest report highlights a significant reduction in coronary #inflammation and residual inflammatory risk as captured by #CCTA imaging using CaRi-Heart AI in women with #BreastCancer 2 years post-RT
#AI #CardioOncology #CardioEd #EHJ
@escardio.bsky.social
Presented at #ACC25:
In the PROTECT-TAVI trial, the routine use of cerebral embolic protection during TAVI did not reduce the incidence of stroke within 72 hours or before discharge from the hospital (if discharge occurred sooner). Full trial results: nej.md/41RONXi
@accintouch.bsky.social
YT link: www.youtube.com/watch?v=to81...
26.03.2025 14:20 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0Ever wondered how interim analyses work in #RCTs? ๐ Check out our Stats, STAT! video at NEJM Evidence: @nejm.org @ai.nejm.org @sarahgorey.bsky.social evidence.nejm.org/doi/full/10.... #MedStats #ClinicalTrials
26.03.2025 14:09 โ ๐ 3 ๐ 3 ๐ฌ 1 ๐ 0Tirzepatide was previously shown to provide sustained weight reductions in adults with #obesity. Longer-term findings in adults with both obesity and prediabetes are summarized in a new Quick Take video. youtu.be/c9uazgSdDJc
#MedSky #EndoSky
๐ซNew research๐ซ Across 6 #RCTs (n=2,257) early invasive management in #female patients with #NSTEACS did not reduce all-cause mortality or MI risk at 6 months vs. delayed management. #AHAJournals @drroxmehran.bsky.social @vijaykunadian.bsky.social
www.ahajournals.org/doi/10.1161/...
In the HELIOS-B trial, researchers assessed the efficacy and safety of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy. NEJM Editorial Fellow Christos Kotanidis, MD, DPhil, summarizes the results. Full trial: nej.md/3X5nl5Q
#MedSky #CardioSky @cpkotanidis.bsky.social
EDITORIAL โWhat can we do to counter the current chaos? At the least, we can try to maintain order. In our roles as editors, this means continuing to do what we think makes a difference: publishing the highest-quality research, analysis, opinion, and educational content that can improve patient health.โ โOrder out of Chaosโ by NEJM Editor-in-Chief Eric J. Rubin, M.D., Ph.D.
In a new editorial, NEJM Editor-in-Chief Eric J. Rubin, MD, PhD, comments on the effects of the raft of executive orders from the current administration on scientific research and public health. Read the full editorial: nej.md/4gXeRFW
#MedSky
๐คRecurrent severe abdominal pain with no clear cause? In the latest #NEJMDoubleTake we unpack a perplexing case with a broad differential, key clinical clues, and a surprising diagnosis. ๐ฅ๐ฉบ ๐ฅ๐ฌ nejm.org/doi/full/10.... @nejm.org
27.02.2025 14:49 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0